<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04670562</url>
  </required_header>
  <id_info>
    <org_study_id>B-2006/618-311</org_study_id>
    <nct_id>NCT04670562</nct_id>
  </id_info>
  <brief_title>Longitudinal Follow up of Patients With Pleural Effusion</brief_title>
  <official_title>Longitudinal Follow up of Patients With Pleural Effusion in South Korea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the clinical course of patients diagnosed with pleural effusion&#xD;
      and determine various clinical factors and biomarkers associated that can predict the&#xD;
      diagnosis and clinical outcome and prognosis of patients with pleural effusion due to&#xD;
      specific causes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who presented to Seoul National University Bundang Hospital with pleural effusion&#xD;
      would be recruited. Pleural fluid and blood samples would be collected. All patients will&#xD;
      receive routine diagnostic procedures and medical care and treatments according to the&#xD;
      diagnosis; the original cancer if diagnosed with malignant effusion, and managements for&#xD;
      pleural effusion control. Patients would be observed for the clinical course and prognosis up&#xD;
      to 3 years without any interventions caused by this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>From date of diagnosis of malignant pleural effusion until the date of death, assessed up to 36 months.</time_frame>
    <description>Mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease progression</measure>
    <time_frame>From date of diagnosis of malignant pleural effusion until the date of first documented disease progression, assessed up to 36 months.</time_frame>
    <description>Progression of original malignancy or new metastasis occured</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pleural Effusion, Malignant</condition>
  <condition>Prognosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Pleural fluid samples and blood samples will be collected from each participants.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who presented with pleural effusion and undergo diagnostic/therapeutic&#xD;
        thoracentesis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presented with pleural effusion&#xD;
&#xD;
          -  Patients who undergo thoracentesis and fluid analysis for diagnosis and management&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who refuse to be enrolled&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yeon Wook Kim, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yeon Wook Kim, Professor</last_name>
    <phone>82-10-7497-5586</phone>
    <email>kimyw@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeon Wook Kim, Professor</last_name>
      <phone>82-10-7497-5586</phone>
      <email>kimyw@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>April 15, 2021</last_update_submitted>
  <last_update_submitted_qc>April 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion, Malignant</mesh_term>
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

